As survivin is a key IAP protein in cancer and significant reduction was observed in MDA-MB-231 cells in apoptotic arrays following 24 h treatments (Fig. 5b), Western blotting was performed on a greater concentration range for 48 h in each cell line. This evidence concerns the gene BIRC5 and cancer.